MATERIAL EVENT4967.TTSE

Kobayashi Pharmaceutical: change of representative director

Summary

KOBAYASHI PHARMACEUTICAL CO., LTD. filed an extraordinary report via EDINET on 2025-01-21 17:01 JST. Reason(s) cited: extraordinary report.

Open the price chart on TradingView.

Source: EDINET S100V4A9 ↗ · PDL1.0 · Not investment advice